Acacia spray dried powder
Acacia allergenic extract is used in allergenic testing.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(12)
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal) (TA1061)
Suspected neurological conditions: recognition and referral (NG127)
Multiple sclerosis in adults: management (NG220)
Coeliac disease: recognition, assessment and management (NG20)
MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's (HTG733)
Mitochondrial disorders in children: Co-enzyme Q10 (ES11)
Vitamin B12 deficiency in over 16s: diagnosis and management (NG239)
Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues (HTG535)
Suspected neurological conditions: recognition and referral (QS198)
Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate (ESUOM4)
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215)
Bipolar disorder: assessment and management (CG185)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 6 · 1966–2025
Showing the 50 most relevant studies, sorted by most relevant.
C. Sanchez, Michaël Nigen, Verónica Mejia Tamayo, et al.
Food Hydrocolloids, 2017
Engelbrecht I, Horn SR, du Plessis JL
2025
Abeer Hashem, Elsayed Fathi Abd Allah, Abdulaziz A. Alqarawi, et al.
Frontiers in Microbiology, 2016
Weijun Chen, Xiaobin Ma, Wenjun Wang, et al.
Food Hydrocolloids, 2018
R. Raguvaran, Balvinder K. Manuja, Meenu Chopra, et al.
International Journal of Biological Macromolecules, 2016
- Alginates
- Anti-Bacterial Agents
- Fibroblasts
Rabeea M. A. Daoub, Aarif H. El‐Mubarak, Misni Misran, et al.
Journal of the Saudi Society of Agricultural Sciences, 2016
Lydie‐Stella Koutika, David M. Richardson
Forest Ecosystems, 2019
Sosuke Ogawa, Yoshikazu Yazaki
Molecules, 2018
- Acacia
- Anti-Bacterial Agents
- Antineoplastic Agents
Pablo Souza‐Alonso, Jonatan Rodríguez, Luís González, et al.
Annals of Forest Science, 2017
Anabela Borges, Helena Manuel de Azevedo Ferreira José, Vera Homem, et al.
Antibiotics, 2020
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Acacia
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Molecular structure
Linked open data from Wikidata (Q535814), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. Molecular structure images from Wikimedia Commons.